Insiders · Profile

Cannon Gillian

Director at Xenon Pharmaceuticals. Filing since 5 Jun 2026. CIK 0001833910

Company

Date

Role

Action

Shares

Amount

Of holding

XENE Xenon Pharmaceuticals Inc.

5 Jun 2026

Director

Sold on a plan

1,190

$63.24K

45.0%

1 decision on file.